Publication | Open Access

Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function

Long-term ReductionHeart FailureCardiovascular DiseaseMedicinePhysiologyCaspase-1 InhibitionCardiovascular PharmacologyMyocardial Infarct SizePharmacotherapyPharmacologyCardiologyAcute Myocardial InfarctionMyocardial Infarction